A detailed history of Ridgecrest Wealth Partners, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Ridgecrest Wealth Partners, LLC holds 11,658 shares of MRK stock, worth $1.16 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares
11,658
Previous 11,272 3.42%
Holding current value
$1.16 Million
Previous $1.4 Million 5.16%
% of portfolio
0.7%
Previous 0.84%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$111.15 - $128.97 $42,903 - $49,782
386 Added 3.42%
11,658 $1.32 Million
Q4 2023

Jan 09, 2024

SELL
$100.18 - $109.02 $300 - $327
-3 Reduced 0.03%
11,272 $1.23 Million
Q3 2023

Oct 25, 2023

SELL
$102.95 - $114.33 $25,737 - $28,582
-250 Reduced 2.17%
11,275 $1.16 Million
Q2 2023

Jul 31, 2023

BUY
$108.61 - $118.38 $49,308 - $53,744
454 Added 4.1%
11,525 $1.33 Million
Q4 2022

Jan 26, 2023

SELL
$87.44 - $112.11 $4,372 - $5,605
-50 Reduced 0.45%
11,071 $0
Q3 2022

Oct 20, 2022

SELL
$84.53 - $94.96 $735,411 - $826,152
-8,700 Reduced 43.89%
11,121 $958,000
Q2 2022

Jul 29, 2022

SELL
$83.49 - $94.64 $39,490 - $44,764
-473 Reduced 2.33%
19,821 $1.81 Million
Q1 2022

Apr 26, 2022

SELL
$73.51 - $82.4 $30,139 - $33,784
-410 Reduced 1.98%
20,294 $1.67 Million
Q4 2021

Jan 19, 2022

BUY
$72.28 - $90.54 $25,298 - $31,689
350 Added 1.72%
20,704 $1.59 Million
Q3 2021

Nov 03, 2021

BUY
$71.68 - $78.83 $6,307 - $6,937
88 Added 0.43%
20,354 $1.53 Million
Q2 2021

Jul 21, 2021

BUY
$70.31 - $77.77 $79,309 - $87,724
1,128 Added 5.89%
20,266 $1.58 Million
Q1 2021

May 19, 2021

BUY
$68.86 - $81.11 $1.32 Million - $1.55 Million
19,138 New
19,138 $1.48 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Ridgecrest Wealth Partners, LLC Portfolio

Follow Ridgecrest Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ridgecrest Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ridgecrest Wealth Partners, LLC with notifications on news.